TICKERNERD
Menu
EUDAEUDAReal Estate · Real Estate Services

EUDA Stock Forecast: EUDA Health Holdings Ltd. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$14
+1.21% on the day

The 1 Wall Street analysts covering EUDA Health Holdings Ltd. hold a median 12-month price target of $55 — +288.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 4 of 100 as at 15 Aug 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$42.4M
Ticker Nerd rank
4 / 100
Median analyst target
$55
Analysts covering
1
Total return, dividends reinvested
1W
−10.9%
1M
+26.7%
YTD
−69.3%
1Y
−72.8%
From 52W high
−81.8%
From 52W low
+169.4%
$5
$78
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

EUDA stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores EUDA Health Holdings Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Aug 2026
4 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
84
Volatility
40
Momentum
26
Revisions
25
Growth
16
Value
15
Accruals
8
Quality
1
Issuance
0

Size (84): Smaller than most of the companies we track.

Issuance (0): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

EUDA stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on EUDA, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0$20$40$60$80Oct 25Jan 26Apr 26Jul 26EUDAHigh $55Median $55Low $55

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says1 analysts
1 Buy0 Hold0 Sell
Low $55Median $55High $55

The green dot is the last close — the median target sits +288.1% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
9 Mar 2026Greenridge GlobalMaintainsBuy$6.00 → $2.75
9 Mar 2026Greenridge GlobalMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. EUDA appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

EUDA analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−52.9%
Analysts raising
0
Analysts cutting
1
Fundamentals

EUDA Health Holdings Ltd. (EUDA) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
30.0×

Cheaper than 27% of US stocks

Price / sales
6.2×

Cheaper than 22% of US stocks

Price / book
—
EV / EBITDA
−12.9×

Cheaper than 86% of US stocks

Growth & margins
Revenue growth (YoY)
78.9%

Higher than 91% of US stocks

Earnings growth (YoY)
—
Gross margin
26.9%

Higher than 31% of US stocks

Operating margin
−34.8%

Higher than 19% of US stocks

Net margin
−40.7%

Higher than 11% of US stocks

Returns & dividend
Return on equity
65.0%

Higher than 94% of US stocks

Return on assets
−89.3%

Higher than 3% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

EUDA vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelReal Estate Services
CompanyMarket capTKN rank
EUDAEUDA Health Holdings Ltd.$42.4M
4
ASPSAltisource Portfolio Solutions SA$63.6M
35
FTHMFathom Holdings, Inc.$25.7M
24
DUOFangdd Network Group Ltd.$24.5M
12
NYCAmerican Strategic Investment Co.$23.9M
69
MAYSJ.W. Mays, Inc.$83.7M
30
OPADOfferpad Solutions, Inc.$21.1M
61

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own EUDA Health Holdings Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest EUDA news & analysis

EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products

GlobeNewsWire · 30 July 2026positive

EUDA Health announced a non-binding Memorandum of Understanding with GO POSB Organoids and Shenzhen Innovation Immunotechnology to pursue an integrated iPSC cell therapy program for oncology and wellness, targeting global distribution.

Why it matters — The collaboration signals EUDA's potential expansion beyond its core distribution business into advanced cell therapy for oncology and wellness markets.

EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies

GlobeNewsWire · 28 July 2026positive

EUDA Health Holdings Limited has signed a tri-party Memorandum of Understanding with GO POSB Organoids and Shenzhen Innovation Immunotechnology to collaborate on developing next-generation therapies derived from induced pluripotent stem cells (iPSC).

Why it matters — This MOU signals EUDA's expansion beyond its core distribution business into next-generation cell therapy research and development.

FAQ

Frequently asked questions about EUDA stock

What is the EUDA stock price forecast for 2026-2027?

The 1 Wall Street analysts covering EUDA Health Holdings Ltd. have a median 12-month price target of $55, with estimates ranging from $55 to $55. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is EUDA stock a buy right now?

Of the 1 analysts covering EUDA Health Holdings Ltd., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks EUDA Health Holdings Ltd. 4 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank EUDA?

As at 15 Aug 2026, EUDA Health Holdings Ltd. ranks 4 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (84 of 100).

Will EUDA stock go up?

No one can know that. What the data says: the median 12-month target from 1 analysts implies +288.1% from the last close, and Ticker Nerd's factor model ranks EUDA Health Holdings Ltd. 4 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the EUDA stock forecast for 2030?

No analyst covering EUDA Health Holdings Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for EUDA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $55 to $55 over the next 12 months.

How has EUDA stock performed over the past year?

EUDA Health Holdings Ltd. returned -72.8% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does EUDA Health Holdings Ltd. do?

Euda Health Holdings Limited is a non-invasive healthcare provider operating across Singapore, Malaysia, and China, with headquarters in Singapore. The company operates through two primary segments: medical services and property management.

What is the latest news on EUDA?

The most recent item we track (GlobeNewsWire, 30 July 2026): "EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products". EUDA Health announced a non-binding Memorandum of Understanding with GO POSB Organoids and Shenzhen Innovation Immunotechnology to pursue an integrated iPSC cell therapy program for oncology and wellness, targeting global distribution.

Company

About EUDA Health Holdings Ltd.

Euda Health Holdings Limited is a non-invasive healthcare provider operating across Singapore, Malaysia, and China, with headquarters in Singapore. The company operates through two primary segments: medical services and property management. In healthcare, Euda offers specialty care services through medical facility clinics providing holistic treatment for various illnesses, alongside science-backed wellness solutions including stem cell therapies, immune therapies, bioenergy cabin licensing, molecular supplements, and wellness membership programs. The company positions itself as a next-generation health technology provider focused on longevity and regenerative medicine, emphasizing accessibility and affordability of advanced treatments. In parallel, Euda manages properties including shopping malls, office buildings, residential apartments, and condominiums, providing property management and security services to tenants and owners. Listed on NASDAQ, the company integrates digital healthcare ecosystem capabilities while maintaining its diversified revenue base across both healthcare and real estate segments.

CEO Mr. Alfred Lim · 123 employees · Singapore · https://eudahealth.com